Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes
Year: 2019
Type: review
Abstract: Objective: There are currently five widely used definition of prediabetes. We compared the ability of these to predict 5-year conversion to diabetes and investigated whether there were other cut-points identifying risk of progression to diabetes that may be more useful. Research design and methods: We conducted an individual participant meta-analysis using longitudinal data included in the Obesity, Diabetes and Cardiovascular Disease Collaboration. Cox regression models were used to obtain study-specific HRs for incident diabetes associated with each prediabetes definition. Harrell's C-statistics were used to estimate how well each prediabetes definition discriminated 5-year risk of diabetes. Spline and receiver operating characteristic curve (ROC) analyses were used to identify alternative cut-points. Results: Sixteen studies, with 76 513 participants and 8208 incident diabetes cases, were available. Compared with normoglycemia, current prediabetes definitions were associated with four to eight times higher diabetes risk (HRs (95% CIs): 3.78 (3.11 to 4.60) to 8.36 (4.88 to 14.33)) and all definitions discriminated 5-year diabetes risk with good accuracy (C-statistics 0.79-0.81). Cut-points identified through spline analysis were fasting plasma glucose (FPG) 5.1 mmol/L and glycated hemoglobin (HbA1c) 5.0% (31 mmol/mol) and cut-points identified through ROC analysis were FPG 5.6 mmol/L, 2-hour postload glucose 7.0 mmol/L and HbA1c 5.6% (38 mmol/mol). Conclusions: In terms of identifying individuals at greatest risk of developing diabetes within 5 years, using prediabetes definitions that have lower values produced non-significant gain. Therefore, deciding which definition to use will ultimately depend on the goal for identifying individuals at risk of diabetes.
Authors: Crystal Man Ying Lee, Stephen Colagiuri, Mark Woodward, Edward W Gregg, Robert Adams, Fereidoun Azizi, Rafael Gabriel, Tiffany K Gill, Clicerio Gonzalez, Allison Hodge, David R Jacobs Jr, Joshua J Joseph, Davood Khalili, Dianna J Magliano, Kirsten Mehlig, Roger Milne, Gita Mishra, Morgana Mongraw-Chaffin, Julie A Pasco, Masaru Sakurai, Pamela J Schreiner, Elizabeth Selvin, Jonathan E Shaw, Gary Wittert, Hiroshi Yatsuya, Rachel R Huxley
Institutions: The University of Sydney, La Trobe University, Johns Hopkins University, The George Institute for Global Health, UNSW Sydney, University of Oxford, The George Institute for Global Health, Imperial College London, Flinders University, SA Health, Adelaide Institute for Sleep Health, The University of Adelaide, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Instituto de Salud Carlos III, Escuela Nacional de Sanidad, Instituto Nacional de Salud Pública, The University of Melbourne, Cancer Council Victoria, University of Minnesota, The Ohio State University Wexner Medical Center, The Ohio State University, Baker Heart and Diabetes Institute, University of Gothenburg, The University of Queensland, Wake Forest University Health Sciences, Wake Forest University, Barwon Health, Deakin University, Monash University, Kanazawa Medical University, Fujita Health University, Nagoya University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
Funders: U.S. Department of Health and Human Services, Jackson State University, Mississippi State Department of Health, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, Japan Society for the Promotion of Science, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences, National Institute on Minority Health and Health Disparities
Awards: G1114307781, MESA, G1409423729, G1522370804, G1686417863, G1788514665, G1823732541, G190379715, G2081135171, G2262505034, G2262782284, G2316258288, G2415573643, MESA, G2462410987, Health 2020, G265762973, G2780798618, G2809357584, MESA, SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--EBCT READING, G3051506083, G3057025668, G3256118428, G3437799970, G350245564, G3647016462, G3687594596, G3744596180, MESA, G3901643820, G3973572274, G399481048, TITLE: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), G4512137732, G4597579782, G4711807797, G47192932, G4739409156, G4747441672, G4790942633, A life course worksite-based cohort study of frailty and participation from adulthood until after retirement, OPTION 3. 4/1/2014 - 3/31/2015. MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - READING CENTER, NHLBI, G4897018079, The Role of The Renin-Angiotensin-Aldosterone System, ARMC5, and Neprilysin in Glucose Metabolism among African Americans, MESA, G508454511, G5088122703, G5108002584, Research and Mentoring in the Clinical Epidemiology of Type 2 Diabetes, SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-ULTRASOUND, G5352314984, G5770678025, G5787256936, G579045871, G5928944960, G6060132884, G6095866717, G6156766399, G6182174406, G6277886052, G6359107525, Institute for Clinical and Translational Research, MESA, G6514094751, Epidemiology of Chronic Disease, Health Interventions and DNA Studies, G6739173425, G6837735701, G7032370290, G7091571603, G7155745631, Precision Public Health for major cancers - novel approaches to building the genetic, epigenetic and lifestyle knowledge base for assessing risk and prognosis, MESA, G7374887626, G7526106616, G7535686976, Obesity, Pre-diabetes and Future Risk of Diabetes: Maximising the evidence, minimising the cost, Clinical and Translational Science Award, G814392139, Platform of Supporting Cohort Study and Biospecimen Analysis, G833338434, G836417160, G8637122261, G8738262636, G89699440, G916230891
OpenAlex ID: W2998279878
